Stage IIIC Rectal Cancer Active Not Recruiting Phase 1 Trials for Trametinib (DB08911)

IndicationStatusPhase
DBCOND0028694 (Stage IIIC Rectal Cancer)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01740648Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal CancerTreatment